NCT00453011

Brief Summary

Objective: The standard definition of failure in cataract surgery is best corrected visual acuity of less than 20/40 at one year. The specific aim of this cooperative study was to compare the failure rate for those patients with vitreous loss in whom an PC IOL is placed to the failure rate for those in whom an AC IOL is placed after vitreous loss. Design: A total of 437 patients in 15 centers were randomized to AC or PC IOL over a 45-month period and were followed for a minimum of one year. The null hypothesis is that the rate of failure is the same in the two groups. All patients who were about to undergo cataract surgery in the participating centers and who did not meet an exclusion criterion were eligible for the study. At the time of surgery, if there was vitreous loss, and if in the opinion of the surgeon there was sufficient capsular support for a posterior chamber lens to be placed, then the patient was randomized into one of either the anterior or posterior chamber lens groups. The patients were then followed for complications (e.g., retinal detachment, cystoid macular edema, uveitis, glaucoma, hyphema) and for the primary end point of visual acuity of 20/40 or better at one postoperative year. An "Index Group" of about 500 patients without vitreous loss also were followed according to study protocol. These patients were compared to those in the PC and AC IOL groups with respect to outcome and baseline characteristics in order to assess the effect of vitreous loss on complication rates. All patients were followed at annual intervals until the termination of the study. This allowed the study to obtain long-term information with regard to visual acuity and complication rates.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,202

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Feb 1992

Longer than P75 for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 1992

Completed
6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 1998

Completed
9.2 years until next milestone

First Submitted

Initial submission to the registry

March 26, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 28, 2007

Completed
Last Updated

October 20, 2015

Status Verified

October 1, 2015

First QC Date

March 26, 2007

Last Update Submit

October 19, 2015

Conditions

Keywords

vitreous lossintraocular lensesPatients undergoing extracapsular cataract surgeryVitreous loss with sufficient capsular support for an unsutured posterior chamber lens5% random sample of patients with no vitreous loss

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The principal eligibility criterion was a visually significant lens opacity resulting in a best-corrected distance visual acuity of 20/50 or worse.

You may not qualify if:

  • Age less than 18 years
  • Unwillingness to give informed consent
  • Unwillingness to agree to protocol follow-up
  • Visual acuity better than 20/50
  • Any other ocular disease which would preclude a final postoperative visual acuity of 20/40 or better (e.g., proliferative diabetic retinopathy, flaucoma, or Fuchs' dystrophy)
  • History of uveitis
  • Other contraindication to an IOL
  • Cataract attributable to trauma
  • Patient only had one eye with potential for useful vision
  • Any retinal thickening or definite hard exudates within one disk diameter of center of macula
  • Patient's other eye already entered into the study.
  • Patients could be screened for the study twice; once for each eye if they had a cataract in both. However, if the first procedure resulted in the patient being entered into the randomized study, the 5% NVP group, or the ICS group, then the second eye was not eligible for the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Gaster RN, Collins JF. The long-term effect of vitreous presentation during extracapsular cataract surgery on postoperative visual acuity. Am J Ophthalmol. 2007 Aug;144(2):186-194. doi: 10.1016/j.ajo.2007.04.023. Epub 2007 Jun 7.

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED

Study Record Dates

First Submitted

March 26, 2007

First Posted

March 28, 2007

Study Start

February 1, 1992

Study Completion

February 1, 1998

Last Updated

October 20, 2015

Record last verified: 2015-10